NCT02341729View on ClinicalTrials.gov

Effects and Plasma Concentration of Ticagrelor, After Crushed and Non-crushed Intake, After Acute Coronary Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Acute Coronary Syndrome
Interventions
DRUG

ticagrelor

crushed tablets and non-crushed tablets

Trial Locations (1)

9000

Intensive Care Unit, Ghent University Hospital, Ghent

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

University Hospital, Ghent

OTHER